Steroid Flare After Cortisone Joint Injection
A steroid flare is a transient increase in joint pain and inflammation occurring within 24-48 hours after intra-articular corticosteroid injection, affecting approximately 1 in 5 patients (20.7%), and is self-limited, typically resolving within 2-3 days without specific treatment beyond symptomatic management.
What Is a Steroid Flare?
A steroid flare (also called postinjection flare or pain flare) represents the most common adverse event following corticosteroid joint injections, accounting for approximately 75% of all complications 1. This phenomenon manifests as:
- Acute worsening of pain at the injection site
- Increased joint inflammation and warmth
- Onset within 24-48 hours post-injection
- Self-limited duration of 2-3 days in most cases
The incidence ranges from 4.6% to 20.7% across different studies 2, 1, making it a predictable and relatively common occurrence that patients should be counseled about during informed consent.
Clinical Characteristics and Risk Factors
Who Is at Higher Risk?
Younger patients face significantly higher risk of developing a steroid flare. Research demonstrates a 5.5% decreased odds of developing a flare per year of age (P < 0.01) 2. This means a 30-year-old patient has substantially higher risk than a 60-year-old receiving the same injection.
Subtalar joint injections carry independently higher risk compared to other joint locations 1.
What Does NOT Increase Risk?
Importantly, the following factors do not significantly affect flare risk 2:
- Gender/sex
- Body mass index (BMI)
- Pre-injection pain severity
- Type of corticosteroid used
- Injection location (except subtalar joint)
Management Approach
Immediate Post-Injection Care
Avoid overuse of the injected joint for 24 hours following injection; however, immobilization is discouraged 3. This represents the key EULAR guideline recommendation for post-injection management.
Treatment of Active Flare
When a steroid flare occurs:
- Reassure the patient this is a known, self-limited reaction
- Apply ice to the affected joint for symptomatic relief
- Use oral NSAIDs or acetaminophen for pain control if not contraindicated
- Continue gentle range-of-motion exercises (avoid immobilization)
- Monitor for 48-72 hours - most flares resolve spontaneously within this timeframe
Critical Distinction: Flare vs. Infection
You must differentiate a benign steroid flare from septic arthritis, though infection is exceedingly rare. Red flags for infection include:
- Fever or systemic symptoms
- Progressive worsening beyond 72 hours
- Severe erythema and warmth
- Joint effusion with purulent appearance
Note that no infections were reported in a large cohort of 1,708 ankle/subtalar injections 1, emphasizing the rarity of this complication.
Patient Counseling
Pre-Injection Discussion
Patients should be informed that:
- 1 in 5 patients experience temporary pain increase after injection
- Younger patients have higher risk of this reaction
- Pain typically worsens within 24-48 hours then improves
- This does not indicate infection or treatment failure
- Most patients who obtain relief do so within 3 days (60.4%), and over 93.7% within one week 2
Setting Realistic Expectations
The therapeutic benefit timeline is important: while flares occur early, corticosteroid injections provide mild to moderate pain relief lasting up to 3 months 4, with effects approaching statistical insignificance at 4 months. This helps patients understand that temporary flare symptoms do not negate the overall treatment benefit.
Common Pitfalls to Avoid
- Do not immobilize the joint - this contradicts evidence-based guidelines 3
- Do not assume infection - steroid flares are far more common than septic arthritis
- Do not prescribe antibiotics empirically for typical flare presentations
- Do not dismiss younger patients' concerns - acknowledge their higher risk and provide extra counseling
- Do not repeat injection during active flare - wait for resolution and reassess benefit
The steroid flare represents a predictable, benign, and self-limited reaction that requires primarily supportive care and patient reassurance rather than aggressive intervention.